Cargando…

Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress

SIMPLE SUMMARY: Friedreich’s ataxia is the most common form of inherited ataxia, with an estimated prevalence of 1:50,000 in Caucasians. With no cure and a reduced lifespan, Friedreich’s ataxia is a devastating neurodegenerative disease. At the present time, the treatment strategies are aimed at spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lew, Sze Yuen, Mohd Hisam, Nur Shahirah, Phang, Michael Weng Lok, Syed Abdul Rahman, Syarifah Nur, Poh, Rozaida Yuen Ying, Lim, Siew Huah, Kamaruzzaman, Mohd Amir, Chau, Sze Chun, Tsui, Ka Chun, Lim, Lee Wei, Wong, Kah Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136261/ https://www.ncbi.nlm.nih.gov/pubmed/37106759 http://dx.doi.org/10.3390/biology12040559

Ejemplares similares

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
por: Lee, F. Y., et al.
Publicado: (1987)

l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations
por: Mota, Pedro, et al.
Publicado: (2019)

Effects of Buthionine Sulfoximine Treatment on Cellular Glutathione Levels and Cytotoxicities of Cisplatin, Carboplatin and Radiation in Human Stomach and Ovarian Cancer Cell Lines(*): – Glutathione, Buthionine Sulfoximine, Cytotoxicity –
por: Lee, Kyung Shik, et al.
Publicado: (1992)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

Neuroprotective effects of Hericium erinaceus (Bull.: Fr.) Pers. against high-dose corticosterone-induced oxidative stress in PC-12 cells
por: Lew, Sze Yuen, et al.
Publicado: (2020)

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986)

In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
por: Gemma, S, et al.
Publicado: (1994)

The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)
por: Chen, Jun, et al.
Publicado: (2005)

Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review
por: Phang, Michael Weng Lok, et al.
Publicado: (2021)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Enhancement of Antitumor Activity of Cisplatin on Human Gastric Cancer Cells in vitro and in vivo by Buthionine Sulfoximine
por: Saikawa, Yoshiro, et al.
Publicado: (1993)

Glutathione Depletion by L-Buthionine-S,R-Sulfoximine Induces Apoptosis of Cardiomyocytes through Activation of PKC-δ
por: Kim, Young-Ae, et al.
Publicado: (2013)

Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells
por: Salvi, Ankita, et al.
Publicado: (2016)

The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats
por: Smith, Ian C, et al.
Publicado: (2015)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

Editorial: Natural products for neuroprotection and neuroregeneration
por: Wong, Kah Hui, et al.
Publicado: (2023)

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
por: Tagde, A, et al.
Publicado: (2014)

Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
por: Cruz, Adriana, et al.
Publicado: (2020)

Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review
por: Lew, Sze Yuen, et al.
Publicado: (2022)

Neurogenesis-dependent antidepressant-like activity of Hericium erinaceus in an animal model of depression
por: Chong, Pit Shan, et al.
Publicado: (2021)

Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
por: Akan, Ilhan, et al.
Publicado: (2005)

Malaysian brown macroalga Padina australis mitigates lipopolysaccharide-stimulated neuroinflammation in BV2 microglial cells
por: Subermaniam, Kogilavani, et al.
Publicado: (2023)

PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
por: Marengo, Barbara, et al.
Publicado: (2011)

Hericium erinaceus Promotes Anti-Inflammatory Effects and Regulation of Metabolites in an Animal Model of Cerebellar Ataxia
por: Chau, Sze Chun, et al.
Publicado: (2023)

Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway
por: Chowdhury, Avik Acharya, et al.
Publicado: (2013)

Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination
por: Rao, Zhiping, et al.
Publicado: (2023)

BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine
por: Tanaka, Yukie, et al.
Publicado: (2014)

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
por: Savarino, Andrea, et al.
Publicado: (2009)

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE
por: Delbart, Wendy, et al.
Publicado: (2023)

Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence
por: Nor Hisam, Nur Syahidah, et al.
Publicado: (2021)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
por: Mohamad Anuar, Nur Najmi, et al.
Publicado: (2020)

Synthesis and Transformations of NH‐Sulfoximines
por: Andresini, Michael, et al.
Publicado: (2021)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review
por: Wong, Kah-Hui, et al.
Publicado: (2022)

Intramolecular cyclization of N-cyano sulfoximines by N–CN bond activation
por: Seo, Ye Ji, et al.
Publicado: (2023)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6hhmmnu2id3j5ue75upej4ig8d